Physician profile
Mark S Cohen
NPI 1952380669
$78,059.05
in general payments reported to CMS, 2019-2025
12 companies · $7,870 in 2025
The $7,870 reported for 2025 was more than what 92% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $14K · 2021: $11K · 2022: $9,401 · 2023: $10K · 2024: $9,401 · 2025: $7,870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $27K · Consulting Fee: $500 · Food and Beverage: $304 · Travel and Lodging: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $26,772.94 |
| Consulting Fee | $500.00 |
| Food and Beverage | $303.65 |
| Travel and Lodging | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $43,511.82 | 2021-2025 | Katalyst Bipolar Radial Head System |
| Integra Lifesciences Corporation | $32,605.15 | 2019-2021 | |
| Acumed LLC | $587.56 | 2019-2025 | Acumed, Acumed |
| Synthes Gmbh | $554.00 | 2025 | |
| Medwest Associates | $305.00 | 2019 | |
| Medtronic, INC. | $182.06 | 2022-2023 | Intellis Adaptivestim |
| Joint Active Systems, INC. | $98.09 | 2019 | |
| Abbott Laboratories | $74.72 | 2022 | |
| Orthofix Medical, INC. | $51.89 | 2025 | Cervical-Stim |
| Stryker Corporation | $46.99 | 2024 | Prostep Mica |
| Pfizer INC. | $27.23 | 2023 | |
| Journey Medical Corporation | $14.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.